COMMUNIQUÉS West-GlobeNewswire

Normunity announces first patient dosed in Phase 1 clinical study of NRM-823, a T Cell Engager against a novel tumor-specific target, in patients with solid tumors
05/11/2025
Phase 1a/1b study will evaluate NRM-823 as monotherapy and in combination with immune checkpoint inhibition in patients with locally-advanced or metastatic refractory solid tumors NRM-823 is a T cell engager against an [...]
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
05/11/2025
BRISBANE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class 1 targeted and immune-mediated therapeutics to [...]
Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
05/11/2025
Company Completes the Required Infrastructure to Support the Introduction of LIBERTY® to the U.S. Market with the Hiring of the Core Commercial Team and Establishing Logistic Partnership Interest and Overwhelmingly [...]
Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
05/11/2025
Company to host conference call to discuss financial results and provide a corporate update on November 12, 2025 at 4:30 p.m. ET SCOTTSDALE, Ariz., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey [...]
Standard Dental Labs Signs Binding Agreement to Acquire Dream Dentistry Labs, LLC, Strengthening Central Florida Operations
05/11/2025
ORLANDO, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (OTCQB: TUTH) (“SDL” or the “Company”) today announced that it has signed a binding agreement on November 4 th , 2025 to acquire Dream Dentistry [...]
Outset Medical to Present at the 2025 Stifel Healthcare Conference
05/11/2025
SAN JOSE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Solana Company (NASDAQ: HSDT) Releases Investor Update
05/11/2025
NEWTOWN, Pa., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury dedicated to [...]
Precision Neuroscience and SCI Ventures Partner to Bring Brain–Computer Interfaces to People Living with Paralysis
05/11/2025
NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Precision Neuroscience Corporation (Precision), a leading brain–computer interface (BCI) company, today announced an investment from SCI Ventures, the world’s first specialist [...]
NewGenDigital Appointed as SAXA Inc.’s Agent for Tokenization of US$100 Million of Gold-backed Assets
05/11/2025
Service agreement with SAXA, Inc. appoints NewGenDigital as SAXA’s worldwide tokenization agent, strengthening cooperation between the two companies ahead of proposed reverse merger Value of tokenized assets could be [...]
Merit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
05/11/2025
The target lesion primary patency (TLPP) 1 and access circuit primary patency (ACPP) 2 of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) remain superior to percutaneous transluminal angioplasty (PTA) through 24 [...]
StoryMD Launches “My StoryMD Journeys,” an AI-Powered Health Platform That Transforms an Individual’s Fragmented Medical Records into a Unified and Personalized Health Narrative
05/11/2025
Combines proprietary AI technology with the largest medical content and visual library in the world to empower users across every stage of their health journey NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Today, StoryMD [...]
Oculis to Participate in Upcoming November Investor Conferences
05/11/2025
ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical [...]
Oculis to Participate in Upcoming November Investor Conferences
05/11/2025
ZUG, Switzerland, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical [...]
Maple acquires Beyond ADHD to expand responsible ADHD and mental health care across Canada
05/11/2025
Acquisition strengthens access to clinically led virtual ADHD and mental health programs nationwide TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Maple, Canada’s leading virtual care company, today announced the [...]
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
05/11/2025
Marks Aclarion’s first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and spinal surgery Experiencing strong commercial traction in UK as first market [...]
RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets
05/11/2025
RadNet subsidiary DeepHealth to commercialize a robust end-to-end remote-imaging offering featuring both TechLive™ remote scanning technology and Alpha RT’s MRI staffing services and training programs LOS ANGELES, Nov. [...]
Immuron IMM-529 IND approved by FDA
05/11/2025
Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) application and clinical study may proceed FDA assigned an IND number (032095) for the IMM-529 [...]
Palvella Therapeutics Announces New QTORIN™ Product Candidate, QTORIN™ Pitavastatin, for the Treatment of Disseminated Superficial Actinic Porokeratosis (DSAP), a Rare, Chronic, and Pre-Cancerous Genetic Skin Disease with No FDA-Approved Therapies
05/11/2025
DSAP is a premalignant, progressive disease characterized by numerous expanding lesions which significantly impact quality-of-life; no FDA-approved therapies exist for the estimated more than 50,000 diagnosed U.S. [...]
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
05/11/2025
MELBOURNE, Australia and INDIANAPOLIS, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) will participate in the upcoming UBS Global Healthcare Conference in Palm Beach, FL [...]

Pages